SCHEMBL6828405

SCHEMBL6828405

Cc1ccc(S(=O)(=O)Nc2ccc(SC#N)cc2[N+](=O)[O-])cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.57
TDP1 Q9NUW8 2/20 0.57
POLB P06746 2/20 0.51
PKM P14618 1/20 0.51
ALDH1A1 P00352 3/20 0.49
CRHBP P24387 3/20 0.46
CRHR2 Q13324 3/20 0.46
HSP90AA1 P07900 2/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
ALOX12 P18054 1/20 0.42
CYP19A1 P11511 1/20 0.42
ATIC P31939 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6832023 0.85 MAPT (0.61) MAPTTDP1POLBPKMALDH1A1
SCHEMBL6553589 0.81 MAPT (0.60) MAPTTDP1POLBPKMALDH1A1
SCHEMBL6554533 0.81 MAPT (0.60) MAPTTDP1POLBPKMALDH1A1
SCHEMBL6554529 0.81 MAPT (0.59) MAPTTDP1POLBPKMALDH1A1
SCHEMBL14877793 0.80 MAPT (0.67) MAPTTDP1POLBPKMALDH1A1
SCHEMBL6553599 0.77 MAPT (0.64) MAPTTDP1POLBPKMALDH1A1
SCHEMBL6553178 0.77 MAPT (0.64) MAPTTDP1POLBPKMALDH1A1
SCHEMBL6554561 0.77 MAPT (0.64) MAPTTDP1POLBPKMALDH1A1
SCHEMBL6554678 0.77 MAPT (0.64) MAPTTDP1POLBPKMALDH1A1
SCHEMBL6553174 0.76 MAPT (0.62) MAPTTDP1POLBPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040023938-A1 Sulfonamide derivatives TABUCHI TAKANORI (JP) 2004-02-05 US disclosed
US-6586617-B1 Nontoxic microbiocides such as 4'-chloro-N-ethyl-2'-nitro-p-toluenesulfonanilide, for agricultural or horticultural, prepared by alkylation or nitration SUMITOMO CHEMICAL TAKEDA AGRO COMPANY, LIMITED (JP) 2003-07-01 US disclosed
EP-1174028-A1 SULFONAMIDE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2002-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040023938-A1 Sulfonamide derivatives FPR1, MRM1, SULT1E1 MAPT 4869/4885TDP1 2856/4885POLB 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.